Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice

Mostrar otras versiones (1)

Equitable access to vaccines is necessary to limit the global impact of the coronavirus disease 2019 (COVID-19) pandemic and the emergence of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. In previous studies, we described the development of a low-cost vaccine based on a...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Domínguez, Irene, Martínez, Jose Luis, Slamanig, Stefan, Lemus, Nicholas, Liu, Yonghong, Lai, Tsoi Ying, Carreño, Juan Manuel, Singh, Gagandeep, Schotsaert, Michael, Mena, Ignacio, McCroskery, Stephen, Coughlan, Lynda, Krammer, Florian, García-Sastre, Adolfo, Palese, Peter, Sun, Weina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241906/
https://www.ncbi.nlm.nih.gov/pubmed/35658571
http://dx.doi.org/10.1128/spectrum.01538-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241906/
https://www.ncbi.nlm.nih.gov/pubmed/35658571
http://dx.doi.org/10.1128/spectrum.01538-22

Ejemplares similares